Categories: Health

Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

 | Source: Boundless Bio, Inc.

SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) — Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that   Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference.

The fireside chat session is scheduled for Monday, June 9, in Miami, FL, at 9:20 a.m. ET. A live and archived webcast of the session will be accessible under “Events & Presentations” in the Investors section of Boundless Bio’s website.

About Boundless Bio

Boundless Bio is a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics to address the significant unmet need of patients with oncogene amplified tumors. Boundless Bio’s research focuses on extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in 14% to 17% of cancer patients. Boundless Bio is developing the first ecDNA-directed therapeutic candidate (ecDTx), BBI-355, which is an oral inhibitor of checkpoint kinase 1 (CHK1) being evaluated in a Phase 1/2 clinical trial in patients with oncogene amplified cancers. Boundless Bio’s next ecDTx, BBI-825, is an oral inhibitor of ribonucleotide reductase (RNR) that has been evaluated in a Phase 1/2 clinical trial in cancer patients with resistance gene amplifications. Boundless Bio is also conducting IND-enabling studies of BBI-940, a potentially first-in-class orally bioavailable, potent Kinesin degrader. Boundless Bio is headquartered in San Diego, CA.

For more information, visit www.boundlessbio.com.

Follow us on LinkedIn and X.

Contacts:
James Lee, Boundless Bio
jlee@boundlessbio.com

Investors
THRUST Strategic Communications
Renee Leck
renee@thrustsc.com

GlobeNews Wire

Recent Posts

ACM Research Delivered Its First High-Throughput Ultra Lith KrF Track System to a Leading Chinese Logic Wafer Fab Customer

September 07, 2025 20:00 ET  | Source: ACM Research, Inc. New Ultra Lith KrF Track…

6 hours ago

DataGlobal Hubs GDAI 2025 Showcases the Worlds Brightest Minds in Data and AI

PHOENIX, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Global Data & AI Virtual Tech Conference (GDAI…

6 hours ago

WSPN Completes Acquisition of Aplauz NL B.V.

TORTOLA, British Virgin Islands, Sept. 8, 2025 /PRNewswire/ -- Worldwide Stablecoin Payment Network (WSPN), a leading…

6 hours ago

ECOVACS Robotics Launches Biggest-Ever Diwali Sale in India: Up to 70% Off Smart Cleaning Robots

Discounts across DEEBOT and WINBOT ranges, including the debut of 'mini but mighty' models. MUMBAI,…

6 hours ago

KFSHRC to Partake Tomorrow as Strategic Partner in C3 Davos of Healthcare New York Summit

NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre…

14 hours ago

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX:…

14 hours ago